Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Amidino-benzimidazole is a synthetic small molecule belonging to the benzimidazole class, characterized by a benzene ring fused to an imidazole ring with an amidine group at the 5-position. It has been studied primarily as an experimental compound and is not approved for clinical use. Benzimidazoles and their derivatives are known for diverse biological activities, including antimicrobial, antiparasitic, antiviral, anticancer, anti-inflammatory, and antifungal effects. The introduction of an amidino group to the benzimidazole core can enhance certain pharmacological properties such as antimicrobial or antiprotozoal activity[1][9][10]. However, there is no specific information available on its mechanism of action or primary therapeutic indication in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-amidino-benzimidazole.